Search

Lloyd A Gall

Examiner (ID: 2758, Phone: (571)272-7056 , Office: P/3673 )

Most Active Art Unit
3508
Art Unit(s)
2899, 3676, 3627, 3642, 3508, 3675, 3501, 3673
Total Applications
4022
Issued Applications
3063
Pending Applications
150
Abandoned Applications
809

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 16793000 [patent_doc_number] => 20210122817 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-04-29 [patent_title] => ANTI-MS4A6A ANTIBODIES AND METHODS OF USE THEREOF [patent_app_type] => utility [patent_app_number] => 16/965675 [patent_app_country] => US [patent_app_date] => 2019-01-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 45517 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16965675 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/965675
ANTI-MS4A6A ANTIBODIES AND METHODS OF USE THEREOF Jan 30, 2019 Abandoned
Array ( [id] => 16871524 [patent_doc_number] => 20210164991 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-06-03 [patent_title] => INDUCED COMMON ANTIBODY RESPONSE [patent_app_type] => utility [patent_app_number] => 16/954187 [patent_app_country] => US [patent_app_date] => 2019-01-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16910 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -20 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16954187 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/954187
INDUCED COMMON ANTIBODY RESPONSE Jan 15, 2019 Pending
Array ( [id] => 14309653 [patent_doc_number] => 20190144530 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-05-16 [patent_title] => TREATMENT OF ALZHEIMER'S DISEASE SUBPOPULATIONS WITH POOLED IMMUNOGLOBULIN G [patent_app_type] => utility [patent_app_number] => 16/247141 [patent_app_country] => US [patent_app_date] => 2019-01-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21577 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16247141 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/247141
TREATMENT OF ALZHEIMER'S DISEASE SUBPOPULATIONS WITH POOLED IMMUNOGLOBULIN G Jan 13, 2019 Abandoned
Array ( [id] => 14566955 [patent_doc_number] => 20190211084 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-07-11 [patent_title] => ANTI-COMPLEMENT FACTOR C1Q ANTIBODIES AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 16/239685 [patent_app_country] => US [patent_app_date] => 2019-01-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 35376 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -21 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16239685 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/239685
Anti-complement factor C1q antibodies and uses thereof Jan 3, 2019 Issued
Array ( [id] => 17859811 [patent_doc_number] => 11440957 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-09-13 [patent_title] => Anti-TMEM106B antibodies and methods of use thereof [patent_app_type] => utility [patent_app_number] => 16/959081 [patent_app_country] => US [patent_app_date] => 2018-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 55405 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 638 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16959081 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/959081
Anti-TMEM106B antibodies and methods of use thereof Dec 20, 2018 Issued
Array ( [id] => 16711928 [patent_doc_number] => 20210079075 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-03-18 [patent_title] => NOVEL MEANS AND METHODS FOR TREATING NEURODEGENERATIVE DISEASES [patent_app_type] => utility [patent_app_number] => 16/956255 [patent_app_country] => US [patent_app_date] => 2018-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29304 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -21 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16956255 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/956255
NOVEL MEANS AND METHODS FOR TREATING NEURODEGENERATIVE DISEASES Dec 19, 2018 Pending
Array ( [id] => 17756254 [patent_doc_number] => 11396538 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-07-26 [patent_title] => Antibodies to centrin-1, methods of making, and uses thereof [patent_app_type] => utility [patent_app_number] => 16/955751 [patent_app_country] => US [patent_app_date] => 2018-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 18 [patent_no_of_words] => 25505 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 781 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16955751 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/955751
Antibodies to centrin-1, methods of making, and uses thereof Dec 19, 2018 Issued
Array ( [id] => 16400136 [patent_doc_number] => 20200340994 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-10-29 [patent_title] => Tumstatin Assay [patent_app_type] => utility [patent_app_number] => 16/956369 [patent_app_country] => US [patent_app_date] => 2018-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5938 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16956369 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/956369
Tumstatin Assay Dec 18, 2018 Abandoned
Array ( [id] => 14338873 [patent_doc_number] => 20190151409 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-05-23 [patent_title] => TREATMENT OF AMD USING AAV2 VARIANT WITH AFLIBERCEPT [patent_app_type] => utility [patent_app_number] => 16/218353 [patent_app_country] => US [patent_app_date] => 2018-12-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20923 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16218353 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/218353
TREATMENT OF AMD USING AAV2 VARIANT WITH AFLIBERCEPT Dec 11, 2018 Abandoned
Array ( [id] => 16861637 [patent_doc_number] => 11020359 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-06-01 [patent_title] => Method, compositions and device for nano-enhanced opto-chemical trans-differentiation of cells and tissues [patent_app_type] => utility [patent_app_number] => 16/215578 [patent_app_country] => US [patent_app_date] => 2018-12-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 17 [patent_no_of_words] => 9248 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16215578 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/215578
Method, compositions and device for nano-enhanced opto-chemical trans-differentiation of cells and tissues Dec 9, 2018 Issued
Array ( [id] => 18215207 [patent_doc_number] => 11590120 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-02-28 [patent_title] => Psilocybin compositions [patent_app_type] => utility [patent_app_number] => 16/211281 [patent_app_country] => US [patent_app_date] => 2018-12-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5427 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16211281 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/211281
Psilocybin compositions Dec 5, 2018 Issued
Array ( [id] => 18345171 [patent_doc_number] => 20230133281 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-05-04 [patent_title] => MATERIALS AND METHODS INCLUDING FOR SEX SELECTION [patent_app_type] => utility [patent_app_number] => 16/768577 [patent_app_country] => US [patent_app_date] => 2018-12-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25746 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16768577 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/768577
MATERIALS AND METHODS INCLUDING FOR SEX SELECTION Dec 2, 2018 Pending
Array ( [id] => 16915881 [patent_doc_number] => 20210188973 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-06-24 [patent_title] => Activity Modulator [patent_app_type] => utility [patent_app_number] => 16/767979 [patent_app_country] => US [patent_app_date] => 2018-11-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4505 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -7 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16767979 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/767979
Activity Modulator Nov 27, 2018 Abandoned
Array ( [id] => 17770459 [patent_doc_number] => 11402394 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-08-02 [patent_title] => Antibodies to TTR and methods of use [patent_app_type] => utility [patent_app_number] => 16/198965 [patent_app_country] => US [patent_app_date] => 2018-11-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 12 [patent_no_of_words] => 14101 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16198965 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/198965
Antibodies to TTR and methods of use Nov 22, 2018 Issued
Array ( [id] => 18172704 [patent_doc_number] => 11572401 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-02-07 [patent_title] => Genetically encoded calcium indicators and methods of use [patent_app_type] => utility [patent_app_number] => 16/198166 [patent_app_country] => US [patent_app_date] => 2018-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5798 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16198166 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/198166
Genetically encoded calcium indicators and methods of use Nov 20, 2018 Issued
Array ( [id] => 16452596 [patent_doc_number] => 20200362022 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-11-19 [patent_title] => METHODS AND COMPOSITIONS FOR THE GENERATION AND USE OF HUMANIZED CONFORMATION-SPECIFIC PHOSPHORYLATED TAU ANTIBODIES [patent_app_type] => utility [patent_app_number] => 16/762141 [patent_app_country] => US [patent_app_date] => 2018-11-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 40290 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -27 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16762141 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/762141
Methods and compositions for the generation and use of humanized conformation-specific phosphorylated tau antibodies Nov 7, 2018 Issued
Array ( [id] => 16437115 [patent_doc_number] => 20200354441 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-11-12 [patent_title] => TREATMENT OF DISORDERS [patent_app_type] => utility [patent_app_number] => 16/760390 [patent_app_country] => US [patent_app_date] => 2018-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 43978 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -32 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16760390 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/760390
TREATMENT OF DISORDERS Oct 29, 2018 Abandoned
Array ( [id] => 14836243 [patent_doc_number] => 20190276522 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-09-12 [patent_title] => ANTIBODIES TO ALPHA-SYNUCLEIN AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 16/170468 [patent_app_country] => US [patent_app_date] => 2018-10-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23637 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -26 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16170468 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/170468
Antibodies to alpha-synuclein and uses thereof Oct 24, 2018 Issued
Array ( [id] => 16930808 [patent_doc_number] => 20210196697 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-07-01 [patent_title] => COMBINATION THERAPIES FOR TREATING BIPOLAR DISORDER AND ADHD, AND METHODS FOR USING THE SAME [patent_app_type] => utility [patent_app_number] => 16/756960 [patent_app_country] => US [patent_app_date] => 2018-10-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29893 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -24 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16756960 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/756960
COMBINATION THERAPIES FOR TREATING BIPOLAR DISORDER AND ADHD, AND METHODS FOR USING THE SAME Oct 23, 2018 Abandoned
Array ( [id] => 15023449 [patent_doc_number] => 20190322729 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-10-24 [patent_title] => COMPOSITIONS AND METHODS RELATED TO K180 DIMETHYLATED H1.0 PROTEIN [patent_app_type] => utility [patent_app_number] => 16/164676 [patent_app_country] => US [patent_app_date] => 2018-10-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 38422 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16164676 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/164676
COMPOSITIONS AND METHODS RELATED TO K180 DIMETHYLATED H1.0 PROTEIN Oct 17, 2018 Abandoned
Menu